RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET Life Science Investing
Candel Therapeutics to Present at Canaccord Genuity's 46th Annual Growth Conference in Boston Life Science Investing
PharmaTher Collaborates with Craft Health to Evaluate CraftMake GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides Life Science Investing
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies Life Science Investing
Opzelura® Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis Life Science Investing
Seer Stockholders Vote to Re-Elect All Seven of Seer's Director Nominees at 2026 Annual Meeting Life Science Investing
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 Life Science Investing
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026 Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
